Pebblebrook Hotel Trust stock price target raised to $14 by Stifel

Published 17/09/2025, 17:28
Pebblebrook Hotel Trust stock price target raised to $14 by Stifel

Investing.com - Stifel raised its price target on Pebblebrook Hotel Trust (NYSE:PEB) to $14.00 from $13.00 while maintaining a Buy rating on the hotel real estate investment trust. The company, currently valued at $1.42 billion, has shown strong momentum with double-digit returns over the past three months, according to InvestingPro data.

The price target increase follows Pebblebrook’s announcement of a $400 million issuance of 1.625% Convertible Senior Notes due 2030 through a private placement. This move comes as InvestingPro analysis shows the company trading below its Fair Value, with a healthy current ratio of 1.78 indicating strong short-term liquidity position.

The notes will have an initial conversion rate of 62.9129 per $1,000 principal, equating to a conversion price of approximately $15.89, representing a 37.5% conversion premium based on the previous day’s closing price.

Stifel noted that negotiated caps increase the potential conversion price to $24.43 per share, which aligns with the upper end of Pebblebrook’s current net asset value per share.

The research firm views this debt issuance as positive for Pebblebrook, stating it removes a significant overhang from the stock, with the firm’s financial projections increasing due to both share repurchases and slight interest savings.

In other recent news, Pebblebrook Hotel Trust reported its second-quarter 2025 earnings, showcasing a mixed performance. The company recorded earnings per share (EPS) of $0.06, which was slightly below the forecasted $0.07. However, it exceeded revenue expectations with $407.54 million compared to the anticipated $398.34 million. In a separate development, Pebblebrook announced the pricing of a $400 million convertible senior notes offering due 2030, with net proceeds estimated at approximately $389.7 million. This offering includes an initial $350 million and an additional $50 million following the full exercise of the initial purchasers’ over-allotment option. The company plans to use these proceeds to repurchase some of its existing convertible notes and approximately $50 million of its common shares. Truist Securities recently raised its price target for Pebblebrook Hotel Trust to $11 from $9 while maintaining a Hold rating. The firm also increased its 2025 Adjusted EBITDAre forecast and its AFFO per share estimate.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.